| Patents for C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120) |
|---|
| 11/21/2007 | EP1856099A2 Acridine and quinoline derivatives as sirtuin modulators |
| 11/21/2007 | EP1330440B1 Agent which inactivates pathogens, comprising an element that bonds with nucleic acids and the use thereof |
| 11/20/2007 | US7297555 Amine-reactive quaternary acridinium compounds, e.g., pentafluorophenyloxy-1-carbonyl-4,7,10,13-tetraoxapentadecyl-(15-amino)-3'-sulfonyl-2',6'-dimethylphenyl-N-(3-sulfopropyl)-acridinium-9-carboxylate with increased solubility; chemiluminescent conjugates, especially with antibodies; assay kits |
| 11/13/2007 | CA2248304C Surface modified carbonate materials |
| 11/08/2007 | WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity |
| 11/08/2007 | CA2650683A1 Amine derivative having npy y5 receptor antagonist activity |
| 10/25/2007 | US20070249838 Deprotonation of pyridine, 2-fluoropyridine, or methoxypyridine with (trimethylsilylmethyl)lithium or neopentyllithium; industrial scale; direct deprotonation and minimized nucleophilic attack on an azaaromatic compound results in improved yields and simplified purification schemes for the deprotonation |
| 10/25/2007 | US20070247059 Compound and Organic Light Emitting Device Using the Same |
| 10/17/2007 | CN100343234C Enzyme substrates, culture media containing same and use thereof in order to detect aminopeptidase activity and/or differentiate gram-positive bacteria from gram-negative bacteria |
| 10/09/2007 | US7279502 Such as prostate cancer, prostatitis and benign prostatic hyperplasia; ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane |
| 10/04/2007 | WO2007110228A1 N-heterocyclic compounds and their use in electronic, optoelectronic and electroluminescent components |
| 10/04/2007 | WO2007058568A3 Salts of 9-oxoacridine-10-acetic acid with 1-alkylamino-1-desoxy-polyols |
| 10/03/2007 | EP1840120A1 N-Heterocyclic compounds and their use in electronic, optoelectronic and electroluminiscent components |
| 09/27/2007 | US20070225498 Ultra-Sensitive Chemiluminescent Substrates for Enzymes and Their Conjugates |
| 09/26/2007 | CN101041670A Displays for high resolution images and methods for producing same |
| 09/20/2007 | WO2007104695A1 Quinolin-4-ylhydrazine derivatives as antimalarial agent |
| 09/11/2007 | US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/04/2007 | US7265130 anti-obestic activity; Neuropeptide Y antagonist |
| 08/29/2007 | CN101024624A Oxime derivative, photopolymerisable composition, colour filter and process for producing the same |
| 08/23/2007 | US20070197499 Pharmaceutical compounds |
| 08/22/2007 | CN1332950C Improved compounds for generating chemiluminescence with peroxidase |
| 08/14/2007 | US7256292 Acridinone based multiple ring fluorescent dyes, linkable forms of fluorescent dyes, energy transfer dyes, reagents labeled with fluorescent dyes |
| 08/08/2007 | CN1330614C Diphenyl anthracene derivate and organic electroluminescent apparatus using diphenyl anthracene derivate |
| 08/07/2007 | US7253207 Quinones as disease therapies |
| 08/01/2007 | EP1440314A4 Chemiluminescent compounds and use thereof |
| 07/26/2007 | US20070172878 comprise an acridan ring bearing an exocyclic ketene dithioacetal group and further contain a labeling substituent which permits attachment to compounds of interest; highly stable, and generate chemiluminescence rapidly on demand |
| 07/25/2007 | EP1809288A1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases |
| 07/24/2007 | US7247726 Generating chemiluminescence by reaction with peroxidase compound and detection of signal with analyzing compound |
| 07/19/2007 | US20070167441 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 07/19/2007 | US20070166759 Chemiluminescent compounds |
| 07/12/2007 | US20070161692 Conformationally restricted polyamine analogs as disease therapies |
| 07/10/2007 | US7241513 Fluorene compound and organic luminescent device using the same |
| 07/05/2007 | US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction |
| 07/04/2007 | EP1802727A1 Fluorescent dye compounds, conjugates and uses thereof |
| 06/27/2007 | EP1301485B1 Novel heteroaryl derivatives and the use thereof as pharmaceuticals |
| 06/26/2007 | US7235685 Of tumors and other lesions; phototherapeutic effect is caused by direct interaction of free radicals, the reactive intermediate produced upon photofragmentation of the sulfenate moiety, with the tissue of interest |
| 06/12/2007 | US7230105 9-aminoacridine derivatives and process for the preparation thereof |
| 06/06/2007 | EP1792897A2 Intercalators having affinity for DNA and methods of use |
| 06/06/2007 | DE10051628B4 Einzelsträngiges Oligonukleotid und dessen Verwendung Single-stranded oligonucleotide and its use |
| 05/29/2007 | US7223865 Chromogenic compounds, and use thereof as enzyme substrates |
| 05/24/2007 | CA2631166A1 Salts and mixture of -9-oxoacridine-10-acetic acid with 1-alkylamino-1-desoxy-polyols, pharmaceutical compositions containing said agents and treatment methods |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/16/2007 | CN1315810C Piperazine-bridged tacrine binary derivatives and synthesis method thereof |
| 05/15/2007 | US7217728 For therapy of reperfusion injury |
| 05/03/2007 | US20070099950 Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain |
| 04/17/2007 | USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
| 04/17/2007 | US7205311 Therapeutic acridone and acridine compounds |
| 04/17/2007 | CA2318381C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 03/29/2007 | US20070072256 Optical molecular sensors for cytochrome p450 activity |
| 03/28/2007 | EP1138745B1 Organic electroluminescent element |
| 03/07/2007 | EP1758847A1 Inhibitors of histone deacetylase |
| 03/07/2007 | EP1029016B1 Novel chemiluminescent labeling compounds |
| 03/07/2007 | CN1923797A Pharmaceutical compounds |
| 03/06/2007 | US7186825 Polyamines for treatment of diseases such as cancer or treatment of tumors |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186568 Electrochemiluminescence from acridan compounds |
| 02/28/2007 | EP1757670A2 Organic electroluminescent element |
| 02/27/2007 | US7183413 Aminoquinoline compounds |
| 02/22/2007 | WO2006130736A3 High quantum yield acridinium compounds and their uses in improving assay sensitivity |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/14/2007 | EP0999256B1 Compounds for organic el element and organic el element |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070031854 Novel 10,10'-substituted-9,9'-biacridilidine luminescent molecules their preparation and uses |
| 02/01/2007 | WO2006073424A3 New ultra-sensitive chemiluminescent substrates for enzymes and their conjugates |
| 01/30/2007 | US7169482 Electrolytic cell with anode, cathode and luminescence zones |
| 01/25/2007 | US20070020479 Luminescent-polymer composition |
| 01/24/2007 | CN1296359C Novel heteroaryl derivatives and use thereof as pharmaceuticals |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/09/2007 | US7160923 Polyamine analogues as therapeutic and diagnostic agents |
| 01/09/2007 | US7160896 Therapeutic acridone and acridine compounds |
| 01/09/2007 | CA2203885C Treating red blood cell solutions with anti-viral agents |
| 01/04/2007 | US20070003788 Organic electroluminescence device |
| 01/03/2007 | CN1293057C Ethylenediamine derivatives |
| 12/27/2006 | EP1735621A2 New ultra-sensitive chemiluminescent substrates for enzymes and their conjugates |
| 12/27/2006 | EP1558255B1 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease |
| 12/27/2006 | EP0888290B1 Azulenyl nitrone spin trapping agents, methods of making and using same |
| 12/27/2006 | CN1886367A Fused ring dicationic anti-protozoan agents and their prodrugs |
| 12/27/2006 | CN1291983C Luminescent element material and luminescent element comprising the same |
| 12/26/2006 | US7153968 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease, eosinophilic granuloma, psoriasis and other benign or malignant proliferative skin diseases, endotoxic shock, laminitis in horses, colic in horses, septic shock, ulcerative colitis, Crohn's disease, reperfusion injury |
| 12/20/2006 | CN1882546A Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain |
| 12/14/2006 | WO2006095139A3 Cancer treatment using specific 3,6,9-substituted acridines |
| 12/13/2006 | CN1289466C Pharmaceutical compounds |
| 12/13/2006 | CN1289451C Di-ether used in preparation of Ziegler-Natta catalyst |
| 12/13/2006 | CN1289086C Uses for anti-malarial therapeutic agents |
| 12/07/2006 | WO2006130736A2 High quantum yield acridinium compounds and their uses in improving assay sensitivity |
| 11/16/2006 | WO2006088541A3 Quinoline derivatives and uses thereof |
| 10/31/2006 | US7129360 Using alkylmetal reagents for directed metalation of azaaromatics |
| 10/26/2006 | WO2006094237A3 Acridine and quinoline dervatives as sirtuin modulators |
| 10/24/2006 | CA2442615C A reduced ignition propensity smoking article |
| 10/18/2006 | CN1280276C 9-aminoacridine derivatives and process for the preparation thereof |
| 10/17/2006 | US7122671 Aryl acridinium ester linked by an ester to an N-succinimidyl ring; undergoing a light emitting reaction in the presence of a dilute aqueous solution of sodium hydroxide and hydrogen peroxide; linked to a monoclonal antibody or other protein in a two-site immunoassay |
| 10/03/2006 | US7115630 Metabotropic glutamate receptor antagonists |
| 09/20/2006 | EP1373213B1 A process for the synthesis of an annulated pyridine base |
| 09/14/2006 | WO2006095139A2 Cancer treatment using specific 3,6,9-substituted acridines |
| 09/14/2006 | US20060202179 Chemiluminescent Acridinium Compounds and Analogues thereof as Substrates of Hydrolytic Enzymes |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/08/2006 | WO2006094237A2 Acridine and quinoline dervatives as sirtuin modulators |
| 09/08/2006 | WO2006092395A1 9-amino-acridine derivatives and their use for eliminating misfolded proteins |
| 09/08/2006 | CA2599992A1 Acridine and quinoline dervatives as sirtuin modulators |